Long‐Term Outcomes and Prognosis Factors in Patients With Idiopathic Inflammatory Myopathies Based on Myositis‐Specific Autoantibodies: A Single Cohort Study

Objective This study was undertaken to investigate the long‐term survival rates and prognostic factors in patients with idiopathic inflammatory myopathies (IIMs) based on myositis‐specific antibody (MSA) stratification. Methods Exactly 628 patients with an IIM were included. Kaplan‐Meier survival cu...

Full description

Saved in:
Bibliographic Details
Published in:Arthritis care & research (2010) 2023-05, Vol.75 (5), p.1175-1182
Main Authors: Jiang, Wei, Shi, Jingli, Yang, Hongxia, Tian, Xiaolan, Yang, Hanbo, Chen, Qingning, Zhang, Lining, Peng, Qinglin, Wang, Guochun, Lu, Xin
Format: Article
Language:English
Subjects:
Autoantibodies
Cohort analysis
Cohort Studies
Ferritin
Humans
Inflammation
Inflammatory diseases
Lung diseases
Lung Diseases, Interstitial - etiology
Malignancy
Medical prognosis
Melanoma
Musculoskeletal diseases
Myositis
Prognosis
Retrospective Studies
Risk factors
Signal recognition particle
Survival
Transcription Factors
tRNA
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective This study was undertaken to investigate the long‐term survival rates and prognostic factors in patients with idiopathic inflammatory myopathies (IIMs) based on myositis‐specific antibody (MSA) stratification. Methods Exactly 628 patients with an IIM were included. Kaplan‐Meier survival curves, univariate, and multivariate Cox regression were used to analyze the outcomes and risk factors. Results The cumulative 1‐, 5‐, and 10‐year survival rates for IIM patients overall were 91.4%, 82.8%, and 75.6%, respectively. The survival rate in the MSA subset was significantly different (P 
ISSN:2151-464X
2151-4658
DOI:10.1002/acr.24993